Clinical Database for Early Recognition of Lung Involvement in Patients at Risk for Interstitial Lung Disease

What this Trial Is About

Researchers are establishing a clinical database and screening program for patients at risk of Interstitial Lung Disease (ILD), particularly those with systemic diseases that may lead to lung involvement. The study aims to collect detailed clinical data to enhance early detection and understanding of ILD progression. This observational research is sponsored by the Medical University of Graz and focuses on improving patient care through early recognition of lung problems. Participants will be grouped into those undergoing a prospective ILD screening algorithm and those with a prior ILD diagnosis. The study uses chest CT scans to assess lung involvement and observe changes over time. This prospective screening approach helps identify early lung changes in at-risk patients, while the retrospective group provides additional clinical insights. During the study, participants will have lung function measured, including the carbon monoxide diffusing capacity (DLCO) and forced vital capacity (FVC) at the time of ILD diagnosis, with follow-up planned for up to 5 years. Researchers will gather clinical data, imaging results, and lung function tests to monitor disease progression and outcomes. Total participation duration varies, with ongoing data collection to support early diagnosis and better management of ILD.

Database for Interstitial Lung Disease